Organic Active Ingredients TRIZ Cases

Merges IGF-1 with specific amino acids to resolve feed inefficiency while improving immune response and skeletal development.

A honey-based topical vehicle delivers beneficial bacteria to skin, scalp, and hair surfaces.

Topical clofazimine formulations deliver therapeutic doses directly to ulcerated skin, avoiding oral antibiotic side effects and hospitalization requirements.

Modifying the diterpenoid alkaloid core reduces biological toxicity while maintaining strong analgesic efficacy.

STING ligand formulated with alum overcomes reduced vaccine efficacy in newborns by inducing robust immune responses.

Structural modifications of mitragynine create analogs that reduce respiratory depression and addiction liability while treating pain and mood disorders.

Partitioning PCR reactions into discrete droplets reduces assay noise and detects low-level MGMT promoter methylation.

Tripolyphosphate bridges stabilize 10 nm gelatin nanoparticles, enabling deep tumor tissue penetration beyond the 50 nm limit of conventional methods.

Heteroaryl compounds degrade ER-alpha to overcome acquired resistance in metastatic breast cancer.

Combination therapy with inavolisib, palbociclib, and fulvestrant treats PIK3CA-mutant breast cancer.

A drug delivery composition incorporates a polymer-degrading enzyme into a polymer-based matrix to enable controlled release kinetics.

Extract arecoline from areca nut slurry via water agitation, then concentrate the alkaloid in an evaporator to reduce toxic side effects.

Engineered aptamers target conserved viral epitopes to overcome strain-specific vaccine limits and reduce treatment costs.

Modified NK1 receptor antagonists reduce CYP3A4 inhibition to prevent chemotherapy-induced nausea and vomiting without drug interactions.

Exogenous NADH and NRH increase body NAD+ levels to accelerate alcohol metabolism.

Subtherapeutic AAV vectors induce immune tolerance, preventing antibody formation against therapeutic proteins in Pompe disease treatment.

Segmenting the reservoir into a drug-loaded zone and a drug-free core minimizes unreleased waste while maintaining consistent release rates.

Inhibiting CCL2-CCR2 signaling reduces medication overuse and prevents chronification by targeting distinct mechanisms.

Systemic administration of intact bacterially derived minicells bypasses the blood-brain barrier to deliver therapeutic agents directly to brain tumors.

A glucokinase activator enhances insulin secretion and improves glycemic control in subjects with untreated or treatment-resistant diabetes.

Platinum(IV) prodrugs reduce systemic toxicity by activating only within tumors.

Th1 and Th2 cytokine biomarkers predict oncolytic virus treatment responsiveness.

Aryl linked imidazole and triazole derivatives inhibit the CYP3A4 enzyme to improve drug pharmacokinetics.

Specific CpG-ODN motifs overcome low activity on rabbit TLR9, enabling potent antibody responses without conventional adjuvant toxicity.

An aptamer-anticancer agent composition delivers therapeutic payloads directly to malignant cells through specific molecular binding.

Silica gel matrices control nitric oxide release to eliminate toxicity and remove bulky equipment requirements.

Gold nanoparticle-steroid complexes reduce pro-inflammatory cytokines and promote M2 macrophage repolarization to treat inflammatory diseases.

Segmented supraparticles increase payload capacity while maintaining structural stability for sustained drug delivery.

Supercritical CO2 extraction isolates cholestenol compounds to detoxify morphine dependence within 7-15 days.

Merges CFD and C5 inhibitors to block intravascular and extravascular hemolysis in paroxysmal nocturnal hemoglobinuria patients.

Positioning the single aperture on the capsule side wall prevents unintentional powder leakage while maintaining simple manufacturing and assembly.

Modified benzodiazepine structures resolve the trade-off between antiviral efficacy and pharmacokinetic properties across diverse patient populations.

Glycomimetic compounds inhibit selectins, improving life expectancy by resolving trade-offs between treatment efficacy and compound complexity.

Determining urinary indoxyl sulfate levels via 1H-NMR to assess prebiotic efficacy.

Combining GABAA receptor positive allosteric modulators with activating ligands reduces inflammatory responses and promotes regulatory immunity.

Morpholine derivatives with varied aryl substituents enhance renin inhibition activity for treating hypertension.

Smac mimetics neutralize inhibitor of apoptosis proteins, reversing chemoresistance and restoring tumor cell sensitivity to TRAIL-induced apoptosis.

Tylosin A derivatives kill adult filarial worms via cuticle disruption, resolving the trade-off between efficacy and safety in restricted patient populations.

Specific heteroaryl structures achieve selective PARP-1 inhibition, reducing intestinal and hematological toxicity while maintaining bioavailability.

Radiolabeled unsaturated nitrogen heterocyclic compounds enable diagnostic imaging of PDE10 receptors in the brain while treating neuropsychiatric disorders.

Synergistic FGFR4 and EGFR inhibition reduces tumor growth in hepatocellular carcinoma while lowering toxicity risks.